MarketCap
Milestone Pharmaceuticals MIST
€ 0.57
-7.33%
Facebook
X
Telegram
Milestone Pharmaceuticals P/CF | MIST
P/CF Jährlich Milestone Pharmaceuticals
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -2.95 | -2.52 | -1.13 | -2.29 | -6.25 | -2.3 | -6.73 | - | - | - | - | - | - | - | - |
Jährliche Entwicklung
Kennzahlen zur Anzeige auswählen
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| -1.13 | -6.73 | -3.45 |
P/CF anderer Aktien in der Pharmaeinzelhändler
| Name | P/CF | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
 |
Lumos Pharma
LUMO
|
-0.791 | - | - | $ 35.3 M |  USA |
 |
Syros Pharmaceuticals
SYRS
|
-1.51 | - | -8.44 % | $ 3.4 M | USA |
 |
Gamida Cell Ltd.
GMDA
|
-5.85 | - | -18.25 % | $ 5.04 M |  Israel |
 |
Citius Pharmaceuticals
CTXR
|
-0.321 | $ 0.45 | 13.31 % | $ 4.98 M | USA |
 |
Aravive
ARAV
|
-0.928 | - | -13.39 % | $ 1.45 M | USA |
 |
Bellerophon Therapeutics
BLPH
|
-4.42 | - | -74.18 % | $ 955 K | USA |
 |
Novo Nordisk A/S
NVO
|
1.84 | $ 39.12 | 0.17 % | $ 174 B |  Danmark |
 |
Abeona Therapeutics
ABEO
|
-3.3 | $ 4.33 | -1.7 % | $ 229 M | USA |
 |
AIM ImmunoTech
AIM
|
-0.103 | $ 0.16 | 3.97 % | $ 259 K | USA |
 |
Akebia Therapeutics
AKBA
|
4.92 | $ 0.63 | 11.85 % | $ 162 M | USA |
 |
Aldeyra Therapeutics
ALDX
|
-9.8 | $ 0.64 | -2.15 % | $ 38.4 M | USA |
 |
Alnylam Pharmaceuticals
ALNY
|
77.9 | $ 228.15 | 1.84 % | $ 29.9 B | USA |
 |
Altimmune
ALT
|
-4.71 | $ 2.04 | -3.77 % | $ 180 M | USA |
 |
Assembly Biosciences
ASMB
|
-7.51 | $ 19.65 | -0.96 % | $ 220 M | USA |
 |
Ascendis Pharma A/S
ASND
|
243 | $ 245.48 | 0.87 % | $ 14.9 B | Danmark |
 |
Beam Therapeutics
BEAM
|
-9.27 | $ 23.79 | -1.08 % | $ 2.35 B | USA |
 |
Benitec Biopharma
BNTC
|
-34 | $ 8.58 | -0.81 % | $ 399 M | USA |
 |
Capricor Therapeutics
CAPR
|
-20.8 | $ 5.72 | -3.54 % | $ 266 M | USA |
 |
EyeGate Pharmaceuticals, Inc.
EYEG
|
-3.88 | - | -1.52 % | $ 24.7 M | USA |
 |
Cerus Corporation
CERS
|
102 | $ 2.37 | 1.5 % | $ 452 M | USA |
 |
Cullinan Management
CGEM
|
-5.11 | $ 14.55 | 1.25 % | $ 877 M | USA |
 |
Curis
CRIS
|
-0.348 | $ 0.38 | -2.33 % | $ 5 M | USA |
 |
CorMedix
CRMD
|
0.0026 | $ 7.95 | 1.27 % | $ 573 K | USA |
 |
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
-10.3 | $ 14.37 | 3.53 % | $ 929 M | USA |
 |
NuCana plc
NCNA
|
-11.4 K | $ 1.03 | 4.54 % | $ 11.6 B |  Britain |
 |
BioVie
BIVI
|
-0.128 | $ 1.33 | 7.26 % | $ 1.96 M | USA |
 |
CEL-SCI Corporation
CVM
|
-1.16 | $ 1.6 | -1.84 % | $ 12.8 M | USA |
 |
PMV Pharmaceuticals
PMVP
|
-1.16 | $ 1.15 | -9.84 % | $ 60.4 M | USA |
 |
Cytokinetics, Incorporated
CYTK
|
-0.0148 | $ 60.7 | -0.87 % | $ 7.29 M | USA |
 |
Daré Bioscience
DARE
|
-1.71 | $ 0.64 | -0.33 % | $ 7.15 M | USA |
 |
DBV Technologies S.A.
DBVT
|
-23.3 | $ 9.97 | 2.21 % | $ 1.39 B |  France |
 |
Denali Therapeutics
DNLI
|
-5.84 | $ 18.66 | 1.35 % | $ 3.22 B | USA |
 |
Precision BioSciences
DTIL
|
-0.982 | $ 6.4 | -3.61 % | $ 82.1 M | USA |
 |
Dyadic International
DYAI
|
-5.52 | $ 0.43 | 7.72 % | $ 15.6 M | USA |
 |
Enlivex Therapeutics Ltd.
ENLV
|
-4.21 | $ 0.16 | -7.21 % | $ 7.31 M | Israel |
 |
Enanta Pharmaceuticals
ENTA
|
-0.0134 | $ 12.0 | 3.09 % | $ 256 K | USA |
 |
Entera Bio Ltd.
ENTX
|
-12.2 | $ 2.83 | -3.25 % | $ 131 M | Israel |
 |
Passage Bio
PASG
|
-1.44 | $ 3.36 | -0.33 % | $ 10.8 M | USA |
|
Forte Biosciences
FBRX
|
-6.59 | $ 76.99 | 0.03 % | $ 997 M | USA |
 |
Exelixis
EXEL
|
13.2 | $ 65.14 | 0.95 % | $ 17.7 B | USA |
|
Immatics N.V.
IMTX
|
-4.16 | $ 7.16 | -2.12 % | $ 876 M |  Germany |
 |
Aptose Biosciences
APTO
|
-0.0645 | - | -45.71 % | $ 1.2 M |  Canada |
 |
Gilead Sciences
GILD
|
18.3 | $ 158.71 | 1.71 % | $ 197 B | USA |
 |
Grifols, S.A.
GRFS
|
5.01 | $ 7.91 | 4.56 % | $ 5.38 B |  Spain |
 |
GlaxoSmithKline plc
GSK
|
27.9 | $ 51.12 | 0.73 % | $ 207 B | Britain |
 |
Halozyme Therapeutics
HALO
|
14.8 | $ 128.07 | 1.94 % | $ 15.3 B | USA |
 |
Bio-Techne Corporation
TECH
|
38.7 | $ 72.69 | 0.2 % | $ 11.3 B | USA |
 |
Harmony Biosciences Holdings
HRMY
|
4.62 | $ 36.84 | 1.97 % | $ 2.12 B | USA |
 |
Immuron Limited
IMRN
|
-37.6 | $ 0.96 | 0.25 % | $ 222 M |  Australia |
 |
Immunic
IMUX
|
-1.69 | $ 7.28 | -1.75 % | $ 1.13 B | USA |